Concepedia

van der Heijde

VD

3

Publications

44

Citations

3

H-Index

2014

Active since

Affiliations

Pfizer (France)(Current)

van der Heijde is an author at Pfizer (France) specializing in autoimmune disease, osteoarthritis, and rheumatology.

Top concepts

Publications per year

2014–2017

3

Publications

3

Secukinumab, a Monoclonal Antibody to Interleukin-17A, Provides Significant and Sustained Inhibition of Joint Structural Damage in Active Psoriatic Arthritis Regardless of Prior TNF Inhibitors or Concomitant Methotrexate: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

Angelina Collins, van der Heijde, Robert Landewé et al. · Data Archiving and Networked Services (DANS) · 2014 · 19 citations

, , +12

A Randomized, Double-blind, Active-and Placebo-controlled Phase 3 Study of Efficacy and Safety of Ixekizumab, Adalimumab, and Placebo Therapy in Patients Naive to Biologic Disease Modifying Antirheumatic Drugs with Active Psoriatic Arthritis

P.J. Mease, van der Heijde, Christopher T. Ritchlin et al. · Data Archiving and Networked Services (DANS) · 2016 · 14 citations

Flare in axial spondyloarthritis: investigation of meaningful changes in symptomatic outcome measures.

Maxime Dougados, Emily Wood, Laure Gossec et al. · PubMed · 2017 · 11 citations

Rows per page

1–3 of 3